FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

108567007: Moexipril hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
173101012 Moexipril hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
602207014 Moexipril hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
19311000188116 moexipril chlorhydrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
826111000172117 chlorhydrate de moexipril fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Moexipril hydrochloride Is a Product containing moexipril (medicinal product) false Inferred relationship Some
Moexipril hydrochloride Is a Moexipril (substance) false Inferred relationship Some
Moexipril hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Angiotensin-converting enzyme inhibitor (disposition) true Inferred relationship Some
Moexipril hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Moexipril (substance) true Inferred relationship Some
Moexipril hydrochloride Is a Angiotensin-converting enzyme inhibitor true Inferred relationship Some
Moexipril hydrochloride Is a produit chimique catégorisé selon sa fonction false Inferred relationship Some
Moexipril hydrochloride Is a Peptide true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Moexipril hydrochloride 7.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moexipril hydrochloride Inferred relationship Some
Moexipril hydrochloride 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moexipril hydrochloride Inferred relationship Some
Product containing hydrochlorothiazide and moexipril hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moexipril hydrochloride Inferred relationship Some
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moexipril hydrochloride Inferred relationship Some
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moexipril hydrochloride Inferred relationship Some
Product containing precisely hydrochlorothiazide 25 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moexipril hydrochloride Inferred relationship Some
Product containing moexipril hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moexipril hydrochloride Inferred relationship Some
Moexipril hydrochloride 7.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moexipril hydrochloride Inferred relationship Some 1
Moexipril hydrochloride 7.5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Moexipril hydrochloride Inferred relationship Some 1
Moexipril hydrochloride 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moexipril hydrochloride Inferred relationship Some 1
Moexipril hydrochloride 15 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Moexipril hydrochloride Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 25 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moexipril hydrochloride Inferred relationship Some 1
Product containing precisely hydrochlorothiazide 25 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Moexipril hydrochloride Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moexipril hydrochloride Inferred relationship Some 2
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Moexipril hydrochloride Inferred relationship Some 2
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moexipril hydrochloride Inferred relationship Some 2
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Moexipril hydrochloride Inferred relationship Some 2
Moexipril hydrochloride 7.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Moexipril hydrochloride Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Moexipril hydrochloride Inferred relationship Some 2
Product containing precisely hydrochlorothiazide 25 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Moexipril hydrochloride Inferred relationship Some 1
Moexipril hydrochloride 15 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Moexipril hydrochloride Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Moexipril hydrochloride Inferred relationship Some 2
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Moexipril hydrochloride Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 7.5 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Moexipril hydrochloride Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Moexipril hydrochloride Inferred relationship Some 1
Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Moexipril hydrochloride Inferred relationship Some 1

This concept is not in any reference sets

Back to Start